Hans Rommelspacher, Sujoy Bera, Benedikt Brommer, Rachael Ward, Monika Kwiatkowska, Tomasz Zygmunt, Florian Theden, Berk Üsekes, Neriman Eren, Michael Nieratschker, Christoph Arnoldner, Stefan K Plontke, Julian Hellmann-Regen, Reimar Schlingensiepen
Although sudden sensorineural hearing loss (SSNHL) is a serious condition, there are currently no approved drugs for its treatment. Nevertheless, there is a growing understanding that the cochlear pathologies that underlie SSNHL include apoptotic death of sensory outer hair cells (OHCs) as well as loss of ribbon synapses connecting sensory inner hair cells (IHCs) and neurites of the auditory nerve, designated synaptopathy. Noise-induced hearing loss (NIHL) is a common subtype of SSNHL and is widely used to model hearing loss preclinically...
April 9, 2024: Proceedings of the National Academy of Sciences of the United States of America